BeiGene maintained a strong presence at EHA 2026, presenting clinical advances across a broad range…
Browsing: biotech analysis
AbbVie maintained a prominent presence at EHA 2026, presenting a broad portfolio of clinical research…
Incyte and MorphoSys maintained a strong presence at EHA 2026, presenting clinical advances across hematologic…
Amgen maintained a strong presence at EHA 2026, presenting new clinical data across multiple hematologic…
AvenCell emerged as an innovative biotechnology company at EHA 2026, presenting advances in next-generation cellular…
Legend Biotech maintained a strong presence at EHA 2026, showcasing continued advances in cellular immunotherapy…
Johnson & Johnson and its oncology business, Janssen, maintained a significant presence at EHA 2026,…
Novartis maintained a strong scientific presence at EHA 2026, presenting a broad portfolio of clinical…
Eli Lilly and its oncology subsidiary Loxo Oncology maintained a strong presence at EHA 2026,…
Bristol Myers Squibb remained one of the leading innovators at EHA 2026, showcasing a broad…